Syntrix Biosystems, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2001-11-27
- Employees
- 1
- Market Cap
- -
- Website
- http://www.syntrixbio.com
Study of SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT06228053
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
A Randomized Study Investigating Oral Desmetramadol Dose Proportionality and Food Effect In Normal Human Subjects
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04683926
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
Study of SX-682 Alone and in Combination with Oral or Intravenous Decitabine in Subjects with Myelodysplastic Syndrome
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 151
- Registration Number
- NCT04245397
- Locations
- 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
🇺🇸University of Miami, Miami, Florida, United States
🇺🇸AdventHealth Medical Group & Bone Marrow Transplant at Orlando, Orlando, Florida, United States
Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy
- Conditions
- Interventions
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT03664921
- Locations
- 🇺🇸
Endeavor Clinical Trials, LLC, San Antonio, Texas, United States
🇺🇸Orange County Research Institute, Anaheim, California, United States
🇺🇸Core Healthcare Group, Cerritos, California, United States
Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2018-02-13
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT03431974
- Locations
- 🇺🇸
Premier Clinical Research, Spokane, Washington, United States
🇺🇸Dermatology Associates of Seattle, Seattle, Washington, United States
🇺🇸Spectrum Dermatology, Scottsdale, Arizona, United States
Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers
- First Posted Date
- 2017-10-18
- Last Posted Date
- 2017-12-28
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03312777
- Locations
- 🇺🇸
PRA Health Sciences, Salt Lake City, Utah, United States
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab
- Conditions
- Interventions
- First Posted Date
- 2017-05-19
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 77
- Registration Number
- NCT03161431
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸University of Miami, Miami, Florida, United States
🇺🇸MD Anderson, Houston, Texas, United States
Omnitram Pharmacokinetic Study In Healthy Volunteers
- First Posted Date
- 2014-07-31
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT02205554
- Locations
- 🇺🇸
CRI Lifetree Research Center, Salt Lake City, Utah, United States
Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis
- First Posted Date
- 2012-11-12
- Last Posted Date
- 2015-05-20
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 175
- Registration Number
- NCT01724931
- Locations
- 🇺🇦
Communal Establishment of Health Protection, Regional Hospital of Veterans of War, Rheumatology Department, Kharkiv, Ukraine
🇺🇦Department of Hospital Therapy #1, Regional Clinical Hospital for occupational diseases 104, Donetsk, Ukraine
🇺🇦Department of Rheumatology, Communal Establishment of Health Protection "Kharkiv City Clinical Hospital #8", Kharkiv, Ukraine
Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis
- First Posted Date
- 2009-07-10
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- Syntrix Biosystems, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT00937027
- Locations
- 🇺🇸
Baylor Research Institute, Dallas, Texas, United States